Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4
Clinical trial NCT03033329 · COMPLETED
Trial details
- NCT number
- NCT03033329
- Sponsor
- MicuRx
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-03-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.